Healthtech Pre-Seed Investors & VC Firms
1328 firms in this list, with a median first check of $250K. 362 of them lead rounds. Generated from verified public data and updated continuously.
Narya Capital
ColumbusPre-Seed–Late Stage
2 people
Lotux Ventures
MexicoPre-Seed$50K – $100K
SpringTime Ventures
LouisvillePre-Seed–Seed$500K – $1M
4 people
Crossroads Health Ventures
IndianapolisPre-Seed–Series A
6 people
Bluesky Equities Ltd.
CalgaryPre-Seed–Series A
8 people
Catalpa Ventures
GrevenmacherPre-Seed–Series A$330K – $1.6M
5 people
Globalive Capital
TorontoPre-Seed–Growth
8 people
HBM Partners
ZugPre-Seed–Late Stage$5M – $50M
5 people
Improve Ventures
BarcelonaPre-Seed–Series A$100K – $1M
5 people
NewMargin Ventures
ShanghaiPre-Seed–Late Stage$425K – $200M
5 people
Sandpiper Ventures
HalifaxPre-Seed–Series A$365K
8 people
HTwenty
MiamiPre-Seed–Series A
4 people
Future Positive Capital
Pre-Seed–Series A
4see Ventures
Chêne-BougeriesPre-Seed–Series B$432K – $1.1M
2 people
High Street Equity Partners
WashingtonPre-Seed–Seed$10K – $250K
2 people
Coelius Capital
San FranciscoPre-Seed–Seed$200K – $1M
1 person
MIRAIDOOR Co. Ltd.
KyotoPre-Seed–Growth$933K – $58M
1 person
MOHARA
LondonPre-Seed–Seed
7 people
Proofpoint Capital
PhoenixvillePre-Seed–Series A
7 people
Company Ventures
New YorkPre-Seed–Seed$500K – $1.5M
3 people
Dementia Discovery
LondonPre-Seed–Series C
6 people
HTGF
BonnPre-Seed–Series A$1.1M
3 people
SPRINT Accelerator
MoscowPre-Seed–Growth
Supernode Global
LondonPre-Seed–Series A
Related lists
Pre-Seed Investors & VC Firms (5679)Healthtech Investors & VC Firms (3208)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Pre-Seed Investors & VC Firms in United States (2090)AI & Machine Learning Pre-Seed Investors & VC Firms (1855)Healthtech Investors & VC Firms in United States (1616)SaaS Pre-Seed Investors & VC Firms (1575)Pre-Seed Investors & VC Firms in Global (1485)Fintech Pre-Seed Investors & VC Firms (1477)
Data sourced from public filings and firms' own websites — see our methodology.






































